A trans-fatty acid-rich diet promotes liver tumorigenesis in HCV core gene transgenic mice.


Journal

Carcinogenesis
ISSN: 1460-2180
Titre abrégé: Carcinogenesis
Pays: England
ID NLM: 8008055

Informations de publication

Date de publication:
22 04 2020
Historique:
received: 23 12 2018
revised: 08 06 2019
accepted: 11 07 2019
pubmed: 14 7 2019
medline: 1 9 2020
entrez: 14 7 2019
Statut: ppublish

Résumé

Excess consumption of trans-fatty acid (TFA), an unsaturated fatty acid containing trans double bonds, is a major risk factor for cardiovascular disease and metabolic syndrome. However, little is known about the link between TFA and hepatocellular carcinoma (HCC) despite it being a frequent form of cancer in humans. In this study, the impact of excessive dietary TFA on hepatic tumorigenesis was assessed using hepatitis C virus (HCV) core gene transgenic mice that spontaneously developed HCC. Male transgenic mice were treated for 5 months with either a control diet or an isocaloric TFA-rich diet that replaced the majority of soybean oil with shortening. The prevalence of liver tumors was significantly higher in TFA-rich diet-fed transgenic mice compared with control diet-fed transgenic mice. The TFA-rich diet significantly increased the expression of pro-inflammatory cytokines, as well as oxidative and endoplasmic reticulum stress, and activated nuclear factor-kappa B (NF-κB) and nuclear factor erythroid 2-related factor 2 (NRF2), leading to high p62/sequestosome 1 (SQSTM1) expression. Furthermore, the TFA diet activated extracellular signal-regulated kinase (ERK) and stimulated the Wnt/β-catenin signaling pathway, synergistically upregulating cyclin D1 and c-Myc, driving cell proliferation. Excess TFA intake also promoted fibrogenesis and ductular reaction, presumably contributing to accelerated liver tumorigenesis. In conclusion, these results demonstrate that a TFA-rich diet promotes hepatic tumorigenesis, mainly due to persistent activation of NF-κB and NRF2-p62/SQSTM1 signaling, ERK and Wnt/β-catenin pathways and fibrogenesis. Therefore, HCV-infected patients should avoid a TFA-rich diet to prevent liver tumor development.

Identifiants

pubmed: 31300810
pii: 5531913
doi: 10.1093/carcin/bgz132
pmc: PMC8456504
doi:

Substances chimiques

Dietary Fats 0
Trans Fatty Acids 0
Viral Core Proteins 0
nucleocapsid protein, Hepatitis C virus 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

159-170

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Références

Hepatology. 2002 Jun;35(6):1341-50
pubmed: 12029619
N Engl J Med. 2006 Apr 13;354(15):1601-13
pubmed: 16611951
J Biol Chem. 2015 Jan 30;290(5):3092-105
pubmed: 25477509
J Clin Invest. 2008 Feb;118(2):683-94
pubmed: 18188449
Nat Med. 1998 Sep;4(9):1065-7
pubmed: 9734402
Biochem Biophys Res Commun. 2018 Nov 17;506(1):12-19
pubmed: 30333090
J Biol Chem. 1998 Mar 6;273(10):5678-84
pubmed: 9488698
JAMA Intern Med. 2016 Aug 1;176(8):1134-45
pubmed: 27379574
Pharmacol Ther. 2017 Nov;179:142-157
pubmed: 28546081
Nature. 2012 Feb 01;482(7384):179-85
pubmed: 22297845
Hepatology. 2019 Jan;69(1):420-430
pubmed: 30070383
J Mol Med (Berl). 2004 Jul;82(7):434-48
pubmed: 15175863
Hepatology. 2012 Jul;56(1):118-29
pubmed: 22290395
Arch Toxicol. 2019 Jun;93(6):1713-1725
pubmed: 31004178
Mol Nutr Food Res. 2009 Jul;53(7):897-903
pubmed: 19685549
Nat Rev Endocrinol. 2009 Jun;5(6):335-44
pubmed: 19399016
Prog Lipid Res. 1983;22(3):221-33
pubmed: 6356151
Biochim Biophys Acta Mol Basis Dis. 2017 Dec;1863(12):3170-3182
pubmed: 28844958
Biochim Biophys Acta. 2007 Aug;1773(8):1263-84
pubmed: 17126425
PLoS One. 2010 Mar 02;5(3):e9434
pubmed: 20209147
Oncogene. 1999 Nov 22;18(49):6853-66
pubmed: 10602461
Int J Cancer. 2008 Jan 1;122(1):124-31
pubmed: 17764115
World J Gastroenterol. 2018 Apr 7;24(13):1440-1450
pubmed: 29632425
Cancer Biol Ther. 2006 Jan;5(1):111-7
pubmed: 16397407
J Nutr Biochem. 2017 Jan;39:77-85
pubmed: 27816763
Cancer Cell. 2016 Jun 13;29(6):935-948
pubmed: 27211490
Cancer Res. 2008 Jun 1;68(11):4287-95
pubmed: 18519688
Nature. 2011 Jul 06;475(7354):106-9
pubmed: 21734707
Prog Lipid Res. 1993;32(1):111-22
pubmed: 8415796
Liver Cancer. 2013 Aug;2(3-4):365-6
pubmed: 24400223
J Hepatol. 2011 Apr;54(4):795-809
pubmed: 21145844
Biochim Biophys Acta. 2015 Jul;1852(7):1242-52
pubmed: 25736301
Hepatol Res. 2017 Apr;47(5):405-418
pubmed: 27288988
Cancers (Basel). 2011 May 20;3(2):2462-77
pubmed: 24212819
J Biol Chem. 2000 Jan 28;275(4):2247-50
pubmed: 10644669
Cell Res. 2002 Mar;12(1):9-18
pubmed: 11942415
Mol Cell Biol. 1999 Jan;19(1):1-11
pubmed: 9858526
Oncogene. 2017 Oct 26;36(43):6020-6029
pubmed: 28671671
Genes Dev. 2000 Aug 1;14(15):1837-51
pubmed: 10921899
Biochim Biophys Acta. 2014 Nov;1841(11):1596-607
pubmed: 25178843
Mol Cell Biol. 1994 Feb;14(2):1039-44
pubmed: 8289784
Gastroenterol Res Pract. 2010;2010:362847
pubmed: 21274430
J Gen Virol. 1997 Jul;78 ( Pt 7):1527-31
pubmed: 9225025
J Hepatol. 2014 Feb;60(2):331-8
pubmed: 24096051
N Engl J Med. 2003 Apr 24;348(17):1625-38
pubmed: 12711737
Mol Cell Endocrinol. 2013 Aug 15;375(1-2):157-66
pubmed: 23732116
Nature. 2004 Sep 23;431(7007):461-6
pubmed: 15329734

Auteurs

Xiao Hu (X)

Department of Metabolic Regulation, Shinshu University School of Medicine, Matsumoto, Japan.
Department of Pathophysiology, Hebei Medical University, Shijiazhuang, People's Republic of China.

Xiaojing Wang (X)

Department of Metabolic Regulation, Shinshu University School of Medicine, Matsumoto, Japan.
Department of Gastroenterology, Lishui Hospital, Zhejiang University School of Medicine, Lishui, Zhejiang, People's Republic of China.

Fangping Jia (F)

Department of Metabolic Regulation, Shinshu University School of Medicine, Matsumoto, Japan.

Naoki Tanaka (N)

Department of Metabolic Regulation, Shinshu University School of Medicine, Matsumoto, Japan.
Research Center for Social Systems, Shinshu University, Matsumoto, Japan.

Takefumi Kimura (T)

Department of Gastroenterology, Shinshu University School of Medicine, Matsumoto, Japan.

Takero Nakajima (T)

Department of Metabolic Regulation, Shinshu University School of Medicine, Matsumoto, Japan.

Yoshiko Sato (Y)

Department of Molecular Pathology, Shinshu University School of Medicine, Matsumoto, Japan.

Kyoji Moriya (K)

Department of Infection Control and Prevention, The University of Tokyo, Tokyo, Japan.

Kazuhiko Koike (K)

Department of Gastroenterology, The University of Tokyo, Tokyo, Japan.

Frank J Gonzalez (FJ)

Laboratory of Metabolism, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Jun Nakayama (J)

Department of Molecular Pathology, Shinshu University School of Medicine, Matsumoto, Japan.

Toshifumi Aoyama (T)

Department of Metabolic Regulation, Shinshu University School of Medicine, Matsumoto, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH